3 Stocks That Could Outperform the Markets in 2021

Investors can look to buy stocks such as Green Thumb Industries and Booking Holdings for market-beating returns in 2021.

analyze data

Image source: Getty Images

After a whirlwind 2020, it is quite possible equity markets will take a breather this year. The COVID-19 pandemic continues to weigh on the global populace and governments all around the world are still providing residents with economic benefits to boost consumer spending. Further, energy prices are expected to remain volatile due to another round of lockdowns in Europe and the United Kingdom

However, there are a few companies that could gain momentum in 2021 and generate outsized gains for investors.

A cannabis giant

The first company on the list is leading marijuana player Green Thumb Industries (CNSX:GTII), a stock that has already gained 176% in the last year. Green Thumb is a U.S.-based cannabis company and unlike their Canadian counterparts, pot players south of the border have higher profit margins.

The marijuana sector was a big winner after Joe Biden won the presidential race. It seems very likely that the democrats will legalize cannabis consumption at the federal level which will be a key driver of top-line growth for Green Thumb and peers.

Green Thumb has close to 50 stores located across 11 U.S. states and is a market leader in the Land of Lincoln. Analysts tracking the stock expect Green Thumb to increase sales by 153.6% to $549 million in 2020 and by 53% to $841 million in 2021.

This means the stock is trading at a forward price to 2021 sales multiple of 6.92, which is very reasonable considering its stellar growth rates.

Booking.com

Companies in the travel and tourism sector have been the hardest hit amid the pandemic. But as the world reopens, post the deployment of COVID-19 vaccines, it’s time to take a look at companies such as Booking Holdings (NASDAQ:BKNG).

Booking Holdings has in fact performed well amid the pandemic-induced chaos and is up 9.3% in the last year. In the first nine months of 2020, the company’s sales fell 53% year over- ear while profits were down by a staggering 94%. Investors are likely to remain bullish on booking as travel demand picks up in the second half of 2021.

Booking recently announced a partnership with Crypto.com where the latter’s user base can avail discounts of up to 25% on accommodations on the travel platform. In the press release, Booking disclosed Crypto.com users will gain access to over 400,000 discounted properties as well as 28 million+ accommodation listings. Crypto.com, on the other hand, has over five million users.

Brookfield Renewables

Another red hot stock that will continue to gain momentum this year is Brookfield Renewables (TSX:BEP.UN)(NYSE:BEP). Shares of this renewable energy giant soared 74% in 2020 as investors expect the transition to clean energy to gain pace in the upcoming decade.

Brookfield Renewables is focused on inorganic growth and acquired TerraForm Power in an all-stock deal last year. This will increase the company’s renewable power assets to 19,000 MW. In December 2020, Brookfield announced the acquisition of Exelon’s solar assets for $810 million.

Brookfield owns and operates a diversified portfolio of renewable power assets allowing the firm to generate a steady stream of cash flows. Since the start of 2000, the stock has generated an annual return of 18%, easily outpacing broader indexes.

Its robust cash-generating assets mean Brookfield will be able to increase dividend payouts between 5% and 9%, making it a top pick for dividend and growth investors.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

David Gardner owns shares of Booking Holdings. The Motley Fool owns shares of and recommends Booking Holdings. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »